日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA

携带 PIK3CA 激酶和螺旋结构域突变的 HER2 扩增乳腺癌细胞对靶向治疗的敏感性不同

Joseph P Garay, Rebecca Smith, Kaylyn Devlin, Daniel P Hollern, Tiera Liby, Moqing Liu, Shanta Boddapati, Spencer S Watson, Amanda Esch, Ting Zheng, Wallace Thompson, Darcie Babcock, Sunjong Kwon, Koei Chin, Laura Heiser, Joe W Gray #, James E Korkola #

Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease

一组前列腺癌细胞系对恩杂鲁胺的反应揭示了糖皮质激素受体在恩杂鲁胺耐药性疾病中的作用

Rebecca Smith, Moqing Liu, Tiera Liby, Nora Bayani, Elmar Bucher, Kami Chiotti, Daniel Derrick, Anne Chauchereau, Laura Heiser, Joshi Alumkal, Heidi Feiler, Peter Carroll, James E Korkola

Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes

HER2+ 乳腺癌亚型对 HER2 抑制剂的微环境介导耐药机制不同

Spencer S Watson, Mark Dane, Koei Chin, Zuzana Tatarova, Moqing Liu, Tiera Liby, Wallace Thompson, Rebecca Smith, Michel Nederlof, Elmar Bucher, David Kilburn, Matthew Whitman, Damir Sudar, Gordon B Mills, Laura M Heiser, Oliver Jonas, Joe W Gray, James E Korkola

Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer

三阴性乳腺癌中与 53BP1 对 PARP 抑制反应相关的通路富集基因特征

Saima Hassan, Amanda Esch, Tiera Liby, Joe W Gray, Laura M Heiser